Literature DB >> 15860982

High-density lipoprotein subclass distribution in individuals of Asian Indian descent: the National Asian Indian Heart Disease Project.

H Robert Superko1, Enas A Enas, Purushotham Kotha, Naras K Bhat, Brenda Garrett.   

Abstract

Individuals of Asian Indian descent have significantly higher cardiovascular event rates as compared with other ethnic groups. The authors investigated the prevalence of metabolic disorders linked to coronary artery disease in an Asian Indian male population compared with non-Asian Indian males. Standard lipid measurements did not discriminate between groups, and the Asian Indian group exhibited less of the high coronary artery disease risk small low-density lipoprotein trait. Despite less of the small low-density lipoprotein trait in the Asian Indian group and no difference in high-density lipoprotein cholesterol, the Asian Indian group had a significantly higher prevalence (p < 0.0002) of low high-density lipoprotein 2b, implying impaired reverse cholesterol transport. This observation remained significant in the subgroup of patients with high-density lipoprotein cholesterol over 40 mg/dL, a region felt not to reflect impaired reverse cholesterol transport. Low high-density lipoprotein 2b combined with the higher lipoprotein(a) in the Asian Indian group may help explain the high prevalence of coronary artery disease in this ethnic population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860982     DOI: 10.1111/j.1520-037x.2005.3766.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  12 in total

1.  Can novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants?

Authors:  Sunita Dodani; Yanbin Dong; Haidong Zhu; Varghese George
Journal:  Indian J Hum Genet       Date:  2008-01

Review 2.  Premature Coronary Heart Disease in South Asians: Burden and Determinants.

Authors:  Sarah T Ahmed; Hasan Rehman; Julia M Akeroyd; Mahboob Alam; Tina Shah; Ankur Kalra; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2018-01-27       Impact factor: 5.113

Review 3.  Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions.

Authors:  Ozlem Bilen; Ayeesha Kamal; Salim S Virani
Journal:  World J Cardiol       Date:  2016-03-26

4.  Lipids in South Asians: Epidemiology and Management.

Authors:  Minhal Makshood; Wendy S Post; Alka M Kanaya
Journal:  Curr Cardiovasc Risk Rep       Date:  2019-07-11

5.  The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh.

Authors:  Masuma Akter Khanam; Chengxuan Qiu; Wietze Lindeboom; Peter Kim Streatfield; Zarina Nahar Kabir; Åke Wahlin
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

Review 6.  South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.

Authors:  Latha Palaniappan; Arun Garg; Enas Enas; Henrietta Lewis; Sehrish Bari; Martha Gulati; Cristina Flores; Ashish Mathur; Cesar Molina; Jagat Narula; Shahid Rahman; Jennifer Leng; Francesca Gany
Journal:  J Community Health       Date:  2018-12

Review 7.  Recent trends in epidemiology of dyslipidemias in India.

Authors:  Rajeev Gupta; Ravinder S Rao; Anoop Misra; Samin K Sharma
Journal:  Indian Heart J       Date:  2017-03-06

8.  Dyslipidemia in South Asian patients.

Authors:  Enas A Enas; Vinod Chacko; Suraj George Pazhoor; Hancy Chennikkara; Heyer Paul Devarapalli
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.967

9.  Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy-Comment.

Authors:  Sachidanandam Vivekanandan
Journal:  Indian J Ophthalmol       Date:  2013-04       Impact factor: 1.848

Review 10.  Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes.

Authors:  Enas A Enas; Arun Kuruvila; Pravien Khanna; C S Pitchumoni; Viswanathan Mohan
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.